Silence Therapeutics partners with InteRNA to develop microRNA therapeutics to treat cancer using Silence's AtuPLEX delivery system

Silence Therapeutics plc

U.K. / Small-Cap Biopharma (<$1 billion)

$15.6m on 09/16/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

InteRNA Technologies B.V.

the Netherlands / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced